Search Results (425)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Sheffield, Mark | Person |
Why?
|
| Ethylnitrosourea induces apoptosis and growth arrest in the trophoblastic cells of rat placenta. | Academic Article |
Why?
|
| Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma. | Academic Article |
Why?
|
| A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. | Academic Article |
Why?
|
| Human Placenta-derived Cells (PDA-001) for the Treatment of Moderate-to-severe Crohn's Disease: A Phase 1b/2a Study. | Academic Article |
Why?
|
| Safety and tolerability of human placenta-derived cells (PDA001) in treatment-resistant crohn's disease: a phase 1 study. | Academic Article |
Why?
|
| Allogeneic hematopoietic stem cell transplantation: does it have a place in treating Hodgkin lymphoma? | Academic Article |
Why?
|
| Relative expression of epidermal growth factor receptor in placental cytotrophoblasts and choriocarcinoma cell lines. | Academic Article |
Why?
|
| Diffuse large B-cell lymphoma: is there a place for autologous hematopoietic stem cell transplant in first remission in the era of chemo-immunotherapy? | Academic Article |
Why?
|
| Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies. | Academic Article |
Why?
|
| Endothelin Receptor A Antagonism Prevents Damage to Glycogen-Rich Placental Cells Following Uterine Ischemia-Reperfusion in the Rat. | Academic Article |
Why?
|
| Etoposide induces TRP53-dependent apoptosis and TRP53-independent cell cycle arrest in trophoblasts of the developing mouse placenta. | Academic Article |
Why?
|
| A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation. | Academic Article |
Why?
|
| A Randomized, Placebo-controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile-associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation. | Academic Article |
Why?
|
| Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial. | Academic Article |
Why?
|